Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

APYX MEDICAL CORPORATION (APYX)

60 + Investors. Track Smart Money conviction in APYX. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +8
Streak
2Q ▲
Buyers last Q
60%

Smart Money Signals — APYX

Based on 56 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added APYX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
📊

High ownership — 93% of 3.0Y peak

93% of all-time peak
56 funds currently hold this stock — 93% of the 3.0-year high of 60 funds (reached 2023 Q3). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
🚀

Fast accumulation — +30% more funds vs a year ago

fund count last 6Q
+13 new funds entered over the past year (+30% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 60% buying

33 buying22 selling
Last quarter: 33 funds were net buyers (17 opened a brand new position + 16 added to an existing one). Only 22 were sellers (13 trimmed + 9 sold completely). A clear majority buying is a strong confirmation signal.
➡️

Steady new buyers — ~17 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 5 → 4 → 13 → 17. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

57% of holders stayed for 2+ years

57% conviction (2yr+) 25% medium 18% new
32 out of 56 hedge funds have held APYX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +95% but shares only +19% — price-driven

Value
+95%
Shares
+19%
Last quarter: the total dollar value of institutional holdings rose +95%, but actual share count only changed +19%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🚀

Acceleration phase — new buyers rushing in

4 → 5 → 4 → 13 → 17 new funds/Q
New funds entering each quarter: 5 → 4 → 13 → 17. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Deep conviction — 72% of holders stayed 2+ years

72% veterans 8% 1-2yr 20% new
Of 60 current holders: 43 (72%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
📋

Smaller funds dominant — 12% AUM from top-100

12% from top-100 AUM funds
12 of 56 holders rank in the top 100 by AUM, but together hold only 12% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
3.6
out of 10
Low Exit Risk
Exit risk score 3.6/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Hedge Fund Ownership: APYX

How many hedge funds hold APYX — quarterly history vs. share price
Quarterly hedge fund ownership of APYX vs. share price

Market Analysis: APYX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: APYX

-- --
Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

10 top-rated funds 0 high-conviction
Consensus
4.5
/ 10
breadth
×
Elite
1.2
/ 10
conviction
Hedge Fund Positioning: APYX
2026 Q1 Stats Unlock in 21 days 60 + Investors

Track Smart Money conviction in APYX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 60 49 22.45%
13F Shares 19M 16M 19.28%
Total Value $66M $34M 95.09%
New Positions 17 13 +4
Increased Positions 17 11 +6
Closed Positions 9 4 +5
Reduced Positions 16 8 +8
Total Calls 1 3 -66.67%
Total Puts 3 0 100%
PUT/CALL Ratio 3.0 0.0 Bearish

Statistics: APYX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

60 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in APYX. Verified SEC 13F-HR filings.

Top 8 institutional holders of APYX — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Silverberg Bernstein Capital Management LLC 2.12% 1,041,070 $3.8M
2 Huntleigh Advisors, Inc. 0.16% 245,920 $907K
3 PERKINS CAPITAL MANAGEMENT INC 0.15% 42,000 $155K
4 SALEM INVESTMENT COUNSELORS INC 0.01% 45,500 $168K
5 COMMONWEALTH EQUITY SERVICES, LLC 0.00% 649,061 $2.4M
6 Joel Isaacson & Co., LLC 0.00% 20,500 $76K
7 TRUST CO OF TOLEDO NA /OH/ 0.00% 1,000 $4K
8 SBI Securities Co., Ltd. 0.00% 10
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — APYX MEDICAL CORPORATION (APYX)

What does the Smart Money Trend signal show for APYX?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added APYX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for APYX?

More buyers than sellers — 60% buying: Last quarter: 33 funds were net buyers (17 opened a brand new position + 16 added to an existing one). Only 22 were sellers (13 trimmed + 9 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for APYX holders?

Smaller funds dominant — 12% AUM from top-100: 12 of 56 holders rank in the top 100 by AUM, but together hold only 12% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held APYX?

57% of holders stayed for 2+ years: 32 out of 56 hedge funds have held APYX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.